Curriculum
Module 05 · 45 min

The Skin Microbiome

Dry, moist, and sebaceous — three ecosystems on one organ.

CoreClinicalAdvanced
Core topics

What's covered

  • 01Skin niches: sebaceous (Cutibacterium), moist (Staphylococcus, Corynebacterium), dry (mixed)
  • 02Cutibacterium acnes and acne pathogenesis
  • 03Staphylococcus aureus in atopic dermatitis
  • 04Malassezia and seborrheic dermatitis / dandruff
  • 05Wound healing and the microbiome
  • 06Microbiome-based therapeutics: bacteriotherapy for AD, acne
Learning objectives

By the end of this module you will be able to

  • L01Map the three major skin microenvironments to their dominant microbial residents.
  • L02Explain the role of C. acnes strain-level diversity in acne pathogenesis.
  • L03Describe how S. aureus colonization drives atopic dermatitis flares.
  • L04Evaluate emerging microbiome-based skin therapeutics.
Expected takeaways

What you should walk away believing

  • Skin is three ecosystems, not one — sebaceous, moist, and dry sites host different communities.
  • C. acnes is commensal in healthy skin; specific ribotypes are acne-associated — it's strain, not species.
  • S. aureus dominance in AD is both consequence and driver of flares.
Lesson · Core emphasis

What this means for you

Patient summary

Your skin has different zones with different bacteria — oily areas around your nose and forehead host different microbes than your armpits or forearms. The bacterium linked to acne (C. acnes) actually lives on everyone's skin — only certain strains cause problems. Similarly, eczema flares are associated with overgrowth of Staph aureus.

Clinician summary

Skin microbiome composition is topography-driven: sebaceous sites (Cutibacterium), moist folds (Staphylococcus, Corynebacterium), dry sites (diverse, low-biomass). In acne, strain-level (ribotype) differences in C. acnes matter more than presence/absence. In AD, S. aureus colonization correlates with flare severity and precedes flares in longitudinal studies. Topical bacteriotherapy (e.g., R. mucosa, S. hominis) is in Phase II trials.

Advanced note

CRISPR-based strain tracking and single-cell metagenomics are revealing that what we called 'C. acnes' is a heterogeneous clade with distinct virulence factor profiles. The antimicrobial peptide axis (LL-37, β-defensins) is a bidirectional interface — host AMPs shape the microbiome, and commensals modulate AMP expression.

Case study

Eczema and the microbiome question

Parents of a 6-year-old with moderate atopic dermatitis ask whether 'microbiome-friendly' skincare products could replace their child's topical corticosteroids. They've read about bacteria-based creams online.

Question

How would you explain the role of S. aureus in AD, the current state of bacteriotherapy research, and the importance of not discontinuing proven treatments for unvalidated alternatives?

Evidence-graded claims

What the data says

B
S. aureus colonization drives AD flares
Consistently associated; precedes flares in longitudinal data; bacteriotherapy trials underway.
B
C. acnes strain diversity explains acne susceptibility
Supported by genomic studies; ribotype RT4/RT5 associated with severe acne.
D
Topical probiotics treat acne and eczema
Phase I/II; promising for AD (R. mucosa), minimal data for acne.
Quick quiz

Test yourself

Q1Which microorganism dominates sebaceous skin sites?
Q2What determines whether C. acnes causes acne?
Q3Which organism drives atopic dermatitis flares?
Flashcards

Spaced review

Glossary

Key terms & abbreviations

Cutibacterium acnesC. acnes
Gram-positive anaerobe dominant on sebaceous skin; strain-level variation determines pathogenicity in acne.
Antimicrobial peptidesAMPs
Host-produced peptides (e.g., LL-37, defensins) that shape the skin microbiome and provide innate immune defense.
Further reading

Optional deeper dive